NOMATEN at the 35th Annual Congress of the European Association of Nuclear Medicine

The 35^th Annual Congress of the European Association of Nuclear Medicine (EANM) was held on October 15-19, 2022 in Barcelona, Spain. The EANM Congress with more than 150 Sessions is the most valuable Nuclear Medicine Meeting worldwide. Each year, nearly 7,000 participants and 180 companies use the possibility to discuss the newest trends and findings in the field of Nuclear Medicine.

This year, during the congress were shown remarkable innovations in every area of this specialist field: new whole-body PET tomographs that are now being used clinically, PSMA tracers were incorporated into clinical guidelines, and excellent trials of theranostic radiopharmaceuticals were presented and published. Furthermore, many other new radiopharmaceuticals which facilitate the study and treatment of new targets were introduced, with more and more protocols addressing unmet clinical needs and new applications in operation.

During the congress, Anna Krzyczmonik and Marek Pruszyński from the Radiopharmaceuticals Group at the NOMATEN Centre of Excellence in National Centre of Nuclear Research in Otwock have promoted research and development capabilities of the group on the design, synthesis and preclinical evaluation of novel diagnostic and therapeutic radiopharmaceuticals. Promotion has been done together with a collaborating team from POLATOM.